It's Unlikely That Ikena Oncology, Inc.'s (NASDAQ:IKNA) CEO Will See A Huge Pay Rise This Year [Yahoo! Finance]
Ikena Oncology, Inc. (IKNA)
Company Research
Source: Yahoo! Finance
The overall pay is 44% above the industry average Ikena Oncology's EPS grew by 75% over the past three years while total shareholder loss over the past three years was 89% Shareholders of Ikena Oncology, Inc. NASDAQ:IKNA ) will have been dismayed by the negative share price return over the last three years. What is concerning is that despite positive EPS growth, the share price has not tracked the trend in fundamentals. The AGM coming up on the 7th of June could be an opportunity for shareholders to bring these concerns to the board's attention. They could also try to influence management and firm direction through voting on resolutions such as executive remuneration and other company matters. Here's our take on why we think shareholders may want to be cautious of approving a raise for the CEO at the moment. View our latest analysis for Ikena Oncology Comparing Ikena Oncology, Inc.'s CEO Compensation With The Industry According to our data, Ikena Oncology, Inc. has a market
Show less
Read more
Impact Snapshot
Event Time:
IKNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IKNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IKNA alerts
High impacting Ikena Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
IKNA
News
- Ikena Oncology, Inc. (NASDAQ: IKNA) was downgraded by analysts at Wedbush from an "outperform" rating to a "neutral" rating. They now have a $2.00 price target on the stock, down previously from $8.00.MarketBeat
- Ikena Oncology, Inc. (NASDAQ: IKNA) had its price target lowered by analysts at HC Wainwright from $11.00 to $4.00. They now have a "buy" rating on the stock.MarketBeat
- UPDATE – Ikena Oncology Announces Strategic UpdateGlobeNewswire
- Ikena Oncology Announces Strategic Update [Yahoo! Finance]Yahoo! Finance
- Ikena Oncology Announces Strategic UpdateGlobeNewswire
IKNA
Earnings
- 3/12/24 - In-Line
IKNA
Sec Filings
- 6/10/24 - Form 4
- 6/10/24 - Form 4
- 6/10/24 - Form 4
- IKNA's page on the SEC website